Soleno Therapeutics soleno.life


Public list: Pharma Startups (4732) Portfolio Company Matchmaking M&A (394) Rare Diseases (230)

Soleno Therapeutics (Soleno), formerly Essentialis Therapeutics, is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company is advancing its lead candidate, DCCR, a once-daily oral tablet for the treatment of PWS, into a Phase III clinical development program at the end of 2017. PWS is a rare and complex genetic neurobehavioral/metabolic disorder affecting appetite, growth, metabolism, cognitive function and behavior. DCCR has received Orp...Show all

Soleno Therapeutics (Soleno), formerly Essentialis Therapeutics, is focused on the development and commercialization of therapeutics for the treatment of rare diseases. The company is advancing its lead candidate, DCCR, a once-daily oral tablet for t...Show all

Company (IPO / Went public)

Phone: 650-213-8444

Fax:

1235 Radio Road
Suite 110
Redwood City, 94065
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Soleno Therapeutics $0M Dec 27, 2016
See all 16 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Soleno Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 4 investors
There is no Board of Directors data available for this company. Please select another tab.

Competitors

Company Status Description Investors

Intarcia Therapeutics

Boston, Massachusetts, United States
Alive / ActiveIntarcia Therapeutics is a biopharmaceutical company developing therapies to ensure the best treatment outcome by optimizing patient convenience and adherence. Intarcia is addressing challenging diseases that require long-term chronic therapy by enhancing efficacy and reducing the burden therapies often place on the patient's life. Intarcia's drug development expertise and competitive edge is demonstrated by its ability to stabilize macromolecules and to deliver them in a constant and consistent...Show allLogin to see details

Humanetics Corporation

Minneapolis, Minnesota, United States
Alive / ActiveHumanetics Corporation is a clinical-stage pharmaceutical company engaged in developing and commercializing products to enhance human health and wellbeing in markets with urgent and unmet needs with a focus on radiation modulators for oncology, medical imaging and medical countermeasure uses.Login to see details
See all 16 competitors